Tag:
OTC Derivatives
Latest Headlines
Latest Headlines
Blankfein on Volcker Rule, OTC derivatives
Goldman Sachs CEO Lloyd Blankfein, fresh off only the company's second quarterly loss as a public company, told the audience at a recent Bank of America Merrill Lynch conference that a weaker economy and tougher regulation did not mark a secular shift in financial markets and that an upturn was br
The big picture on SEFs
The term "swap execution facility" (SEF) still vexes a lot of financial services professionals who happen to work outside of the OTC derivatives markets.
It's an ungainly moniker--but not as bad as "dark pool" from a PR perspective--that nevertheless signifies an important development o
Strapped regulators must rely more on companies
When the reform movement got underway, there was lots of fear of draconian measures that banks would find overly burdensome. But the regulators are just as burdened, and if the SEC were to directly manage every reform effort, the results would likely please few banks, investors as well as regulato
Goldman Sachs exerts itself on OTC derivatives, other CFTC issues
We noted recently that Goldman Sachs has changed its ways when it comes to regulatory issues. No longer content to sit back and adjust to regulatory realities--its historic mode of operation--it has transformed itself into a fearsome lobbying powerhouse .
In some ways, it is carrying lots o
Fed derivatives reformer joins Goldman Sachs
What to make of the Bloomberg report that Theo Lubke --a 15-year veteran of the Federal Reserve Board, the man who led the effort to reform OTC derivatives practices on Wall Street--will now join Goldman Sachs? The role, apparently created for him, will allow Lubke to "work cl
ICE Trust controversy escalates post-Dodd-Frank
In the battle for supremacy in the derivatives clearing business, the ICE Trust has long been a powerhouse, especially when it came to credit default swaps, where it was the only game in town for a stretch, always staying a step ahead of the CME. But the regulatory spotlight is hot right now, and
Citigroup lobbyists leave for other jobs
If you're a lobbyist, you live for the kind of opportunities presented by the financial meltdown and the subsequent rush to reform. The value and skill of lobbyists were on display for the entire industry, Congress and the rule-making bureaucracy. By some measures, the banking industry's lobbyists
What to make of Goldman Sachs' move into derivatives clearing?
It's looking more and more like the OTC derivatives clearing provisions of the now-passed Dodd-Frank law will be a big win for the major dealers. They own the main clearinghouse after all, and they loom as big players in the second largest clearing facility.
Goldman Sachs ( NYSE: GS ) has re
Update: State of the reform bill
Congress seems to be working toward a common proposal, making it more likely that historic financial reform legislation will be passed sooner rather than later.
A lot of issues have been decided: The need for a consumer watchdog within the Federal Reserve Board, the need to permanently exempt
Cliff hanger: Will banks be forced to give up derivatives units?
Will the proposal to force big banks to give up their derivatives trading units survive the final Congressional negotiations on what looks to be a historic reform package? It sure looks that way, to the chagrin of Wall Street, which is making its last stand this week .
As of now, the propos
